Abstract:[Objective]To construct the recombinant adenovirus vector co-expressing human vascular endothelial growth fac-tor 165 (VEGF_(165)) and angiogenin-1 (Ang-1), and to observe the expression of target gene after transfection. [Method]Mo-lecular biologic techniques were used to clone the genes of VEGF_(165) and Ang-1, and PCR was used to amplify the DNA se-quence of IRES (internal ribozyme entry site) from pIRES2-EGFP. The genes of VEGF_(165), IRES and Ang-1 were subcloned to pTrack-CMV one by one to get the plasmid named pTrack-CMV-VIA, which contained all the three genes. The linearized shuttle plasmid was cotransformed into BJ5183 bacteria with backbone vector AdEasy-1. Further the recombinant plasmid was packaged and amplified in QBI-293A cells after Pac 1 digestion to get adenovirus vector pAd-VIA. The expression of the gene of interests was evaluated by fluorescence microscopic analysis of GFP expression and enzyme linked immunosorbent assay (ELISA). [Result]The recombinant adenovirus plasmid was consistent with that shown by sequencing and restriction endonucle-ases digestion. The recombinant pAd-VIA vector was packaged and amplified successfully in QBI-293A cells. The titer was 2 ×10~(10) PFU/ml after amplifying. High positive GFP was expressed in the field through fluorescence microscopy after being transfect-ed by recombinant pAd-VIA. ELISA indicated the expression of the target genes. The difference between the tansfected and non-transfected group was significant (P < 0.05). [Conclusion]The recombinant adenovirus vectors containing vascular endothelial growth factor 165 and angiopoietin-I were successfully constructed, thus providing convenient gene transfer tools for constructing the new gene-modified artificial bone.

Construction and Identification of Replication Recombinent Adenovirus Vector of Human TGF-β1 Shrna

Reconstruction and Identification of Adenovirus Expression Vector for Human Transforming Growth Factor Β1

Construction and identification of plasmid vector of RNA interference of transforming growth factor-β1 gene

[Construction of a Recombinant Adenovirus Vector Harboring Human Transforming Growth Factor-Beta Type II Receptor-Igg1fc Fusion Gene].

Construction and Assessment of Short-Hairpin Rna Eukaryotic Expression Vector Targeting Tgf-Beta 1 Labeled by Gfp

Construction of Transforming Growth Factor-β1 siRNA Expression Vector

Construction and Identification of Recombinant Adenovirus Vectors Expressing GFP and Human TERT-VEGF-Bcl-xl Short Hairpin RNA

Cloning of connective tissue growth factor gene and construction of recombinant adenovirus vector Ad5-CTGF

[Construction of Recombinant Adenovirus Vector of Mouse Keratinocyte Growth Factor].

Constrution of Eukaryotic Expression Vector for Human Transforming Growth Factor Β1

[Construction and Identification of Recombinant Adenovirus Vector Containing Tet-on Adjustable NT3 and BDNF Genes].

Construction of recombinant adenovirus coding for the cDNA of human acidic fibroblast growth factor and the research of its gene transfection efficiency and safety

Construction and Target Gene Expression of Recombinant Adenovirus Vectors Containing Vascular Endothelial Growth Factor 165 and Angiopoietin-1

Construction and target gene expression of adenovirus vectors containing angiogenin-1/vascular endothelial growth factor 165

Construction and identification of a recombinant adenovirus vector containing extracellular domain of TβR Ⅱ-RANTES fusion gene

Construction and Expression of Recombinant Adenovirus Containing Human Thymic Stromal Lymphopoietin Gene

Construction of Recombinant Adenovirus Expressing the Small Interfering RNA of Vascular Endothelial Growth Factor-C

Construction and identification of recombinant human bone morphogenetic protein-2 gene adenoviral vector

Construction of TGF-β2-targeting siRNA interference recombinant plasmids

[Construction and Expression of Recombinant Adenovirus Vector Ad5-hTRX-EGFP].

CONSTRUCTION OF ADENO ASSOCIATED VIRUS RECOMBINANT PLASMID OF CONNECTIVE TISSUE GROWTH FACTOR AND ITS EXPRESSION IN HEK293 CELLS